Interestingly, FGFR1-TACC1 and FGFR3-TACC3 fusions have only been detected in IDH-wildtype GB but not in IDH1/2-mutant glioma, indicating the relevance of FGFR-TACC fusions in the malignancy [19]. The gene discussed is IDH1; the disease is central nervous system cancer.